4th Quarter - Report

EDWARDS LIFESCIENCES, LLC for EDWARDS LIFESCIENCES LLC

Firm
Client
Income
—
Expenses
$350,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Ensuring Patient Access to Critical Breakthrough Products (H.R. 5343/S.1717) Policies promoting medical innovation Heart Valve Disease Awareness FDA Reauthorization/FDA User Fees Diversity in Clinical Trials

LobbyistCovered position, as disclosed
JENNIFER KUSKOWSKI —
BRIAN LOOSER —
MEGHAN O'BRIEN —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 1717 (119th), H.R. 5343 (119th)

Medicare/Medicaid MMM

CMS Coverage Policies for Medical Devices CMS Payment Policies for Medical Devices Ensuring Patient Access to Critical Breakthrough Products (H.R. 5343/S.1717) Heart Valve Disease Awareness National Coverage Determination for TAVR Coverage of Transcatheter Tricuspid Valve Replacement Diversity in Clinical Trials Coverage with Evidence Development

LobbyistCovered position, as disclosed
JENNIFER KUSKOWSKI —
BRIAN LOOSER —
MEGHAN O'BRIEN —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5343 (119th), S. 1717 (119th)

Trade (domestic/foreign) TRD

Japan Reimbursement of Medical Devices

LobbyistCovered position, as disclosed
JENNIFER KUSKOWSKI —
BRIAN LOOSER —
MEGHAN O'BRIEN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.